The company reported revenue from operations at Rs 23,129 crore in the quarter under review, up 19.5% from Rs 19,350 crore in the corresponding quarter of the previous financial year.
Segment revenue
— FMCG: The FMCG segment reported a revenue of Rs 15,354.30 crore in Q1FY26 up YoY and QoQ versus Rs 14,341 crore in Q1FY25 and Rs 14,732 crore in Q4FY25. Revenue from cigarettes were reported at Rs 9,554 crore in the quarter under review versus Rs 8,842 crore in Q1FY25 and Rs 9229 crore in Q4FY25.– Agri Business: Q1FY26 revenue stood at Rs 9,724 crore versus Rs 6,998 crore in Q1FY25 and Rs 3,695 crore in Q4FY25.
— Paperboards, Paper & Packaging: Q1FY26 revenue stood at Rs 2,117 crore versus Rs 1,976.85 crore in Q1FY25 and Rs 2,189 crore in Q4FY25.
Resilient Performance
The company which is synonymous with brads like Gold Flake and Navy Cut said that its Q1 performance was resilient despite a challenging operating environment. Strong growth in gross standalone revenue was reported which was up 20% YoY driven by Cigarettes, Agri Business and FMCG (ex notebooks), the company statement said.The Earnings Before Interest, Taxes, Depreciation and Amortisation (EBITDA) was up 3% YoY.In the FMCG category, staples, biscuits, dairy, premium personal wash, Homecare and agarbattis drove the growth while premium portfolio and NewGen channels sustained their high growth trajectory, the company filing said.
ITC Q1 headwinds
The notebooks industry continues to operate under deflationary conditions on account of low-priced paper imports and opportunistic play by local/regional players. Unseasonal rains during the quarter impacted beverages sales.
Cigarettes net segment revenue was up 7.7% YoY and differentiated and premium offerings continue to perform well. Consumption of high cost leaf tobacco inventory weighs on margins and moderation in procurement prices was witnessed in current crop cycle.
Q1 expenses
ITC reported a 27% jump in its June quarter expenses at Rs 16,752 crore versus Rs 13,218 crore. On a sequential basis, it was up 17% over Rs 14,279 crore in Q4FY25. The expenses were made on raw materials, purchases of stock-in-trade & biological assets, employee benefits and finance cost.
